The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
Share
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
Season 2 Episode 30 - How AI, Data Are Boosting FDA's Regulatory Processes
0:0035:53
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
The CAIOs Leading Responsible AI Development Across Government
New AI memos from the Trump administration prompt federal agencies to establish chief AI officers and OMB to launch a new CAIO AI Council.
7m read -
Agentic AI Redefines Federal Innovation
Defense leaders discuss how the rule is ensuring cyber resiliency across the sector.
20m read -
Inside FedRAMP 20x: GSA’s Pete Waterman Talks Speed, Security
FedRAMP 20x is transforming federal cloud authorizations. GSA’s Pete Waterman shares how automation and continuous monitoring are speeding approvals and strengthening security.
24m watch -
New Talent Strategy Targets Industry Role in Federal AI Workforce
The plan outlines how it wants to prioritize efforts for the partnerships that will fuel talent pipelines in emerging industries.
3m read
